The forecasted data for the UK's Nervous System Medicine market shows a steady increase in per capita spending from $74.7 in 2024 to $77.4 in 2028. Considering that the 2023 figures stood at $74.0, this suggests an annual growth rate, with year-on-year variations ranging from approximately 0.9% to 1% over the forecasted period. The compounded annual growth rate (CAGR) over five years (2023-2028) is around 0.9%, indicating a stable but modest upward trend.
Future trends to watch for include:
- Technological advancements in drug delivery systems.
- Rising prevalence of neurological disorders driving demand.
- Potential impacts of healthcare policy changes.
- Emerging market players and competitive dynamics.
